Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahin Merat

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Hepatitis Monthly|November 2, 2016
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineSeyed Moayed Alavian, Behzad Hajarizadeh, Kamran Bagheri Lankarani, et al.
Journal of Gastroenterology and Hepatology|January 30, 2020
The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairmentHossein Poustchi, Sara Majd Jabbari, Shahin Merat, et al.
Archives of Iranian Medicine|December 26, 2015
Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from IranMasoud M Malekzadeh, Homayoon Vahedi, Kimiya Gohari, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)Sara Mobarak, Mehdi Salasi, Ahmad Hormati, et al.
JAMA Oncology|September 28, 2019
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, Christina Fitzmaurice, Degu Abate, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Hepatitis Monthly|November 2, 2016
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineSeyed Moayed Alavian, Behzad Hajarizadeh, Kamran Bagheri Lankarani, et al.
Journal of Gastroenterology and Hepatology|January 30, 2020
The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairmentHossein Poustchi, Sara Majd Jabbari, Shahin Merat, et al.
Archives of Iranian Medicine|December 26, 2015
Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from IranMasoud M Malekzadeh, Homayoon Vahedi, Kimiya Gohari, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)Sara Mobarak, Mehdi Salasi, Ahmad Hormati, et al.
JAMA Oncology|September 28, 2019
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, Christina Fitzmaurice, Degu Abate, et al.
Pageof 14